Chinese Drug Company Sued Over Valsartan With Potential Carcinogen
NEW YORK — A class action was filed Aug. 16 in New York federal court against the manufacturers and retailers of a blood pressure/heart failure drug that allegedly contains a potential...To view the full article, register now.
Already a subscriber? Click here to view full article